Nuclear fusion of signaling pathways.
Janknecht
R
R
Deparment of Biochemistry, Mayo Clinic, Rochester, MN 55905, USA. janknecht.ralf@mayo.edu
Hunter
T
T
D000107:Acetylation; D001253:Astrocytes / Q000166:cytology* / Q000378:metabolism; D055396:Bone Morphogenetic Protein 2; D052004:Bone Morphogenetic Protein Receptors; D019485:Bone Morphogenetic Proteins / Q000378:metabolism / Q000494:pharmacology; D002454:Cell Differentiation; D002467:Cell Nucleus / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism / Q000494:pharmacology*; D004268:DNA-Binding Proteins / Q000378:metabolism; D019281:Dimerization; D005904:Glial Fibrillary Acidic Protein / Q000235:genetics; D006131:Growth Inhibitors / Q000378:metabolism / Q000494:pharmacology; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines / Q000378:metabolism / Q000494:pharmacology; D008954:Models, Biological; D009687:Nuclear Proteins / Q000378:metabolism*; D010766:Phosphorylation; D011401:Promoter Regions, Genetic; D011956:Receptors, Cell Surface / Q000378:metabolism; D018121:Receptors, Cytokine / Q000378:metabolism; D017978:Receptors, Growth Factor; D053606:Receptors, OSM-LIF; D050796:STAT3 Transcription Factor; D015398:Signal Transduction; D051785:Smad Proteins; D015534:Trans-Activators / Q000378:metabolism*; D015533:Transcriptional Activation; D016212:Transforming Growth Factor beta
D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D016207:Cytokines; D004268:DNA-Binding Proteins; D005904:Glial Fibrillary Acidic Protein; D006131:Growth Inhibitors; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines; D009687:Nuclear Proteins; D011956:Receptors, Cell Surface; D018121:Receptors, Cytokine; D017978:Receptors, Growth Factor; D053606:Receptors, OSM-LIF; D050796:STAT3 Transcription Factor; D051785:Smad Proteins; D015534:Trans-Activators; D016212:Transforming Growth Factor beta; D052004:Bone Morphogenetic Protein Receptors